GPP Team

Global PharmaPartners, Inc. (GPP) represents international and domestic pharmaceutical R&D partners in the licensing of their product portfolio to GPP Clients in the USA, Canadian, and around the globe. GPP supports our partners with excellent pipeline selection, portfolio management, sales and marketing analysis, contract negotiations, and mergers and acquisitions. GPP represents a diverse group of R&D partners covering retail, hospital, specialty pharmaceutical, specialty pharma, 505(b)(2) or hybrids, branded/innovative, and biological Rx product portfolios.

GPP's Expertise:

Value Creation with foreign dossiers and converting to FDA standards,
introducing foreign pharmaceutical companies to America's most excellent and successful marketing and commercial partners.
superior value for pharmaceutical deal structuring as compared to our peers.
Deals/Licensing of drug developments from conception stages to drug procurement and brokering.
Regulatory - Filing with FDA, Health Canada, MHRA, EMA, ANVISA, GCC, WHO, and many other regulatory bodies: NDA's (New Drug Applications), BLA's (Biologics License Applications), ANDA's (generic) and 505(b) (2) (or hybrids as known in EU) pharmaceutical product files.
Litigation representation for Paragraph Four opportunities.
Your total solutions provider...

Rob Camerer

CEO

BS Chemistry
BS Chemical Engineering

MBA International Studies

33 years experience in the active ingredients pharmaceutical industry and fine chemicals industry.

Joseph Corsetti

President

MBA, JD, CPA

Executive Management

Business Development and Portfolio Management. Commercial Development, Marketing

Jonathan Camerer

Vice President Marketing

BS Marketing

Bachelors in Marketing

Business Development

Accounting

Event Coordination

Corporate Communications

Josh Camerer

BD Manager

BS Administrative Management

Portfolio Analysis

Pipeline Development

Accounting

Promotional Materials

Graphic Design

Vince Mancinelli

Chief Operating Officer

Bachelors in Biology

Grad studies in Pharmaceutical Sciences

Vince is Chief Operating Officer for GPP. He brings over 37 years of leadership experience in the pharmaceutical industry marked by success in growing start-up businesses and creating value for growth specialty brand and generic companies. His career began at Mylan where he steadily advanced in leadership roles including subsidiary head of UDL Laboratories and Mylan’s Head of North American Operations. Other prior C-level leadership roles include President of Rhodes Pharmaceuticals. He is a strategic adviser / consultant for pharmaceutical companies assisting with product portfolios, business development, product licensing and acquisitions, enterprise innovation, integration, and complex market and commercialization strategies.

Kuntal Chatterjee

Vice President BD

MSc - Microbiology

MBA -Pharmaceutical Mgmt

Kuntal has around 22 plus years of experience in RA, Quality, Portfolio, and BD topics.

He has worked in various senior leadership roles at Dr. Reddys, Sandoz, Woerwag, Apotex, Aurobindo, and Berlin Chemie.

Currently, from Nov 2020. Kuntal is a freelancer BD Consultant for GPP, assisting companies globally with their portfolio and BD strategy to grow their global business and helping them with market access, Licensing needs, Business growth, and M&A activities. He is also assisting senior and board-level introductions with Pharma bosses globally